RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104 | -33.3% | 12,397 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $156 | -23.5% | 12,397 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $204 | +10.3% | 12,397 | 0.0% | 0.02% | +6.7% |
| Q4 2022 | $185 | -99.9% | 12,397 | -2.7% | 0.02% | -40.0% |
| Q3 2022 | $286,000 | +33.6% | 12,747 | 0.0% | 0.02% | +38.9% |
| Q2 2022 | $214,000 | -44.0% | 12,747 | 0.0% | 0.02% | -33.3% |
| Q1 2022 | $382,000 | -2.3% | 12,747 | 0.0% | 0.03% | +8.0% |
| Q4 2021 | $391,000 | 0.0% | 12,747 | +2.8% | 0.02% | -10.7% |
| Q3 2021 | $391,000 | -49.4% | 12,397 | -41.3% | 0.03% | -49.1% |
| Q2 2021 | $773,000 | +5.9% | 21,121 | 0.0% | 0.06% | 0.0% |
| Q1 2021 | $730,000 | -16.9% | 21,121 | 0.0% | 0.06% | -19.1% |
| Q4 2020 | $878,000 | -2.4% | 21,121 | 0.0% | 0.07% | -17.1% |
| Q3 2020 | $900,000 | – | 21,121 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |